HealthDay - WEDNESDAY, Oct. 24 (HealthDay News) -- The addition of thechemotherapy drug, docetaxel, to the standard two-drug regimen used forhead and neck cancers improved the efficacy of the treatment whilereducing the toxicity, two new studies report.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.